文献速递胸部肿瘤头颈与中枢神经肿瘤骨软组织肉瘤与黑色素瘤

靶点可操作性综述:复制压力作为儿童实体恶性肿瘤治疗靶点的系统评价

Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies.
PubMed 文献 · Eur J Cancer · 2021-12-25

该综述采用文献驱动的系统靶点可操作性评价方法,检索2014至2021年PubMed中16种儿童实体瘤的复制压力相关文献,最终纳入145篇出版物。结果显示ATR、CHK1、PARP或WEE1是神经母细胞瘤、骨肉瘤、高级别胶质瘤或髓母细胞瘤中最有前景的靶点,可单药或联合化疗/放疗使用,其他靶点证据有限。

要点

  • 系统评价145篇文献,聚焦DNA修复通路和细胞周期检查点调控。
  • ATR、CHK1、PARP或WEE1在神经母细胞瘤、骨肉瘤、高级别胶质瘤或髓母细胞瘤中最有前景。
  • 其他儿童恶性肿瘤中靶向这些通路可能也有效,但证据更有限。

核心结论

  • ATR、CHK1、PARP或WEE1是神经母细胞瘤、骨肉瘤、高级别胶质瘤或髓母细胞瘤中最有前景的靶点,可单药或联合化疗或放疗使用。
  • 靶向这些通路在其他儿童恶性肿瘤中可能也有效,但证据更有限。
  • ATM和DNA-PK等其他靶点的证据也有限,但在某些恶性肿瘤中显示出有希望的结果,需要在其他肿瘤类型中开展更多研究。

研究设计与样本

  • 文献驱动的系统靶点可操作性综述,检索PubMed 2014至2021年发表的复制压力相关文章,覆盖16种儿童实体肿瘤类型。
  • 符合纳入标准的文章上传至R2信息学平台,由两名独立评审员基于九个预设的概念验证模块进行批判性评估并评分。
  • 模块或评分不一致的文章由第三名独立评审员重新评分,最终共识评分由三名评审员裁定。

主要发现

  • 共系统评价145篇与儿童肿瘤靶向复制压力相关的出版物,重点关注DNA修复通路和细胞周期检查点调控。
  • ATR、CHK1、PARP或WEE1在神经母细胞瘤、骨肉瘤、高级别胶质瘤或髓母细胞瘤中是最有前景的靶点。
  • 其他儿童恶性肿瘤中靶向这些通路的证据更有限。
  • ATM和DNA-PK等其他靶点的证据有限,但在某些恶性肿瘤中显示出有希望的结果。

局限性

  • 其他儿童恶性肿瘤中靶向这些通路的证据更有限。
  • ATM和DNA-PK等其他靶点的证据也有限,需要在其他肿瘤类型中开展更多研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Owing to the high numbers of paediatric cancer-related deaths, advances in therapeutic options for childhood cancer is a heavily studied field, especially over the past decade. Classical chemotherapy offers some therapeutic benefit but has proven long-term complications in survivors, and there is an urgent need to identify novel target-driven therapies. Replication stress is a major cause of genomic instability in cancer, triggering the stalling of the replication fork. Failure of molecular response by DNA damage checkpoints, DNA repair mechanisms and restarting the replication forks can exacerbate replication stress and initiate cell death pathways, thus presenting as a novel therapeutic target. To bridge the gap between preclinical evidence and clinical utility thereof, we apply the literature-driven systematic target actionability review methodology to published proof-of-concept (PoC) data related to the process of replication stress. METHODS: A meticulous PubMed literature search was performed to gather replication stress-related articles (published between 2014 and 2021) across 16 different paediatric solid tumour types. Articles that fulfilled inclusion criteria were uploaded into the R2 informatics platform [r2.amc.nl] and assessed by critical appraisal. Key evidence based on nine pre-established PoC modules was summarised, and scores based on the quality and outcome of each study were assigned by two separate reviewers. Articles with discordant modules/scores were re-scored by a third independent reviewer, and a final consensus score was agreed upon by adjudication between all three reviewers. To visualise the final scores, an interactive heatmap summarising the evidence and scores associated with each PoC module across all, including paediatric tumour types, were generated. RESULTS AND CONCLUSIONS: 145 publications related to targeting replication stress in paediatric tumours were systematically reviewed with an emphasis on DNA repair pathways and cell cycle checkpoint control. Although various targets in these pathways have been studied in these diseases to different extents, the results of this extensive literature search show that ATR, CHK1, PARP or WEE1 are the most promising targets using either single agents or in combination with chemotherapy or radiotherapy in neuroblastoma, osteosarcoma, high-grade glioma or medulloblastoma. Targeting these pathways in other paediatric malignancies may work as well, but here, the evidence was more limited. The evidence for other targets (such as ATM and DNA-PK) was also limited but showed promising results in some malignancies and requires more studies in other tumour types. Overall, we have created an extensive overview of targeting replication stress across 16 paediatric tumour types, which can be explored using the interactive heatmap on the R2 target actionability review platform [https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=imi2_targetmap_v1].

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Keller KM, Krausert S, Gopisetty A, et al. Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies. Eur J Cancer. 2021. PMID: 34963094. doi:10.1016/j.ejca.2021.11.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。